Blunting COVID-19's negative impact: Lessons from Israel's vaccination campaign
Travel Med Infect Dis
.
2021 May-Jun:41:102029.
doi: 10.1016/j.tmaid.2021.102029.
Epub 2021 Mar 16.
Authors
Panagiotis Tsigaris
1
,
Jaime A Teixeira da Silva
2
Affiliations
1
805TRU Way, Department of Economics, Thompson Rivers University, Kamloops, British Columbia, V2C 0C8, Canada. Electronic address: ptsigaris@tru.ca.
2
P. O. Box 7, Ikenobe 3011-2, Kagawa-ken, 761-0799, Japan. Electronic address: jaimetex@yahoo.com.
PMID:
33737163
PMCID:
PMC7962545
DOI:
10.1016/j.tmaid.2021.102029
No abstract available
Publication types
Letter
Comment
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines*
COVID-19*
Humans
Israel
Mass Vaccination
RNA, Messenger
SARS-CoV-2
Substances
COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine